Morgan Lewis

Morgan Lewis have lawyers, scientists and technical specialists serving a broad range of clients, including startup biotechnology firms, large multinational pharmaceutical companies, medical device manufacturers, renowned research hospitals, scientific institutions, etc. As diverse as they are, clients need a comprehensive intergrated legal service that addresses all the business issues and oportunities facing the industry. Morgan Lewis counsel clients in the full spectrum of their business activities, including strategic alliances, joint ventures, M&A, licensings, FDA, healthcare regulation, patents and patent litigation, equity investments and financings.

Contact Details: 2 Gresham Street London EC2V 7PE United Kingdom Tel: +44 (0) 20 7710 5500 Fax: +44 (0) 20 7710 5600 Email: kleyshon@morganlewis.com WWW: www.morganlewis.com/

Loading...

Recent Publications by Morgan Lewis:
An overview of medical malpractice litigation and the perceived crisis. In this overview of medical malpractice litigation in the United States,...	9th June, 2005	Morgan Lewis & Bockius, LLT, Counselors at Law, 1701 Market Street,	Clin Orthop Relat Res. 2005 Apr;(433):8-14.

Press Releases on Morgan Lewis:
Sarnova Expands Senior Management Team	23rd November, 2009	Sarnova, Inc.	LINCOLNSHIRE, Ill., Nov. 23 /PRNewswire/ -- Sarnova, Inc., the nation's leading specialty distributor of health care products in the emergency medical services (EMS) and respiratory markets,
Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia	23rd June, 2009	HTH Worldwide	Award Recognizes Entrepreneurial Excellence in Health Care Services and Products Category PHILADELPHIA, June 23 /PRNewswire/ -- HTH Worldwide, a global health and safety services company, today
Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium	18th June, 2009	Yankee Public Relations LLC	'Funding Biopharma: Strategies for Reaching Investors in a Financial Crisis' Draws Regional Biopharmaceutical Executives, Investment Leaders BASKING RIDGE, N.J., June 18 /PRNewswire/ --
Support Bristol's Highly Qualified Independent Nominees for Advocat Board	19th May, 2009	Bristol Investment Fund, Ltd.	Cash Flow from Ops Shares Outstanding Ratio AVCA $9,478,000 5,680,000 1.67 SKH $63,013,000 37,280,000 1
Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA	7th May, 2009	Cornerstone Therapeutics Inc.	- CORNERSTONE GAINS EXCLUSIVE 10-YEAR LICENSE FOR U.S. COMMERCIAL RIGHTS TO MARKETED RESPIRATORY DRUG, CUROSURF(R), AND RECEIVES CASH PROCEEDS OF $15.5 MILLION - CORNERSTONE RECEIVES FIRST RIGHT OF

BioNews Results for Morgan Lewis:
Stryker unit indicted in marketing scheme: DOJ	Reuters Health:  Oct 30 2009 1:30AM Matching: morgan lewis
Affymetrix, Inc. Q3 Earnings Call Transcript	Seeking Alpha:  Oct 22 2009 4:17AM Matching: morgan lewis
Boston Scientific Company Q3 2009 Earnings Call Transcript	Seeking Alpha:  Oct 21 2009 3:37AM Matching: morgan lewis
FTC Clears $68 Billion Pfizer-Wyeth Merger	Yahoo! Canada:  Oct 19 2009 9:16AM Matching: morgan lewis
Humira and nutrition sales lift Abbott 3Q profit	KLAS-TV:  Oct 16 2009 1:18AM Matching: morgan lewis
Promote your company here: BioNewsCast - Press Release Distribution	→View more Morgan Lewis news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 302 times since April 2007, the link to the organisation's website has been followed 42 times

Search for more companies in London

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Morgan Lewis